Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCElise A. Olsen, Julia Scarisbrick, John A. Zic et al.|Blood|2021Cited by 170
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variantsKathleen Baysac, Ankur Kumar Jindal, Michael J. Ombrello et al.|Journal of Allergy and Clinical Immunology|2023Cited by 53
Pediatric primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: A retrospective analysis and review of the literatureOluwaseyi Adeuyan, Alejandro A. Gru, Celine M. Schreidah et al.|Journal of the American Academy of Dermatology|2025Cited by 3
European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disordersRein Willemze, et al., Assaf Chalid et al.|Universität Zürich, ZORA|2025Cited by 0